Skip to main content
IDYA
NASDAQ Life Sciences

IDEAYA Biosciences Forms Clinical Partnership with Roche for Pancreatic Cancer

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$27.42
Mkt Cap
$2.449B
52W Low
$19.83
52W High
$39.28
52W Position info
38% above low
Off High info
30% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

IDYA sits 38% above its 52-week low of $19.83.

Summary

IDEAYA Biosciences announced a clinical collaboration with Roche to evaluate a combination therapy for MTAP-deleted RAS-mutant pancreatic cancer. The companies will jointly govern the trial and initiate Phase 1 combination cohorts in both pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC). This follows an 8-K filed earlier today and builds on recent positive developments, including a prior collaboration with AstraZeneca and strong Phase 2/3 data for darovasertib. Partnering with a major pharma like Roche validates IDEAYA's pipeline and expands its clinical development efforts into challenging oncology indications.

At the time of this announcement, IDYA was trading at $27.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $19.83 to $39.28. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IDYA - Latest Insights

IDYA
Nov 03, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.36
Real-time Price: $26.17 info
Change: -$5.19 (-17%) info
Market Cap: $2.53B info
IDYA
Nov 03, 2026, 6:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $31.64
Real-time Price: $26.17 info
Change: -$5.47 (-17%) info
Market Cap: $2.53B info
IDYA
Oct 19, 2026, 7:08 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.50
Real-time Price: $26.17 info
Change: -$7.33 (-22%) info
Market Cap: $2.53B info
IDYA
Aug 19, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $37.93
Real-time Price: $26.17 info
Change: -$11.76 (-31%) info
Market Cap: $2.53B info
IDYA
Aug 04, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $36.11
Real-time Price: $26.17 info
Change: -$9.94 (-28%) info
Market Cap: $2.53B info